@article {Onwumere-Idolor2021.09.19.21263803, author = {O. S. Onwumere-Idolor and A. J. Ogugua and E. V. Ezenduka and J. A. Nwanta and A. Anaga}, title = {Prevalence of Antimicrobial Residues in Tissues of Broilers Sold at a Local Market in Enugu State, Nigeria Using the European Four Plate Test}, elocation-id = {2021.09.19.21263803}, year = {2021}, doi = {10.1101/2021.09.19.21263803}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Consumption of animal tissues treated with antimicrobial agents may be deleterious if they contain violative levels of the residues. This study determined antimicrobial residues prevalence in broilers sold at Ikpa market, Nsukka, Nigeria.Methods Tissues from muscle, liver and kidney of 60 commercial broilers (180 samples) were tested for antimicrobial residues using the conventional Four Plate Test.Result Prevalence of 80.0\% (48/60) and 51.7\% (93/180) was recorded in the birds and samples {muscle 40.0\%(24/60); liver 55.0\%(33/60) and kidney 60.0\%(36/60)} respectively. There was no significant association between residue occurrence and tissue type (χ2 (2) = 5.206; p = 0.074). Possible antimicrobial classes detected were: macrolid (50.0\%) at pH 8.0 with Micrococcus luteus; β-lactams and tetracyclines (64.4\%) with Bacillus subtillis at pH 6.0; sulphonamides (53.3\%) at pH 7.2 with Bacillus subtillis, and aminoglycosides (46.8\%) at pH 8.0 with Bacillus subtillis. Twenty-four tissue samples were positive at all four pH levels indicating use of more than one class of antimicrobials during each treatment.Conclusion Antimicrobial residues were detected in commercial broilers (muscles, liver and kidney) sampled at Ikpa Market, Nsukka. This is of public health importance given that antimicrobial residues are not monitored in poultry consumed in Nigeria.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was obtained for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UNIVERSITY OF NIGERIA, NSUKKA FACULTY OF VETERINARY MEDICINE INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are included in the manuscript.}, URL = {https://www.medrxiv.org/content/early/2021/09/21/2021.09.19.21263803}, eprint = {https://www.medrxiv.org/content/early/2021/09/21/2021.09.19.21263803.full.pdf}, journal = {medRxiv} }